LeMaitre Vascular (LMAT) Holds A 15% Undervalued View, Is The Stock Fully Priced?
LeMaitre Vascular (LMAT) closed at $101.32 on July 29, 2026, and is considered 15% undervalued with a fair value of $118.75 based on analyst forecasts and a strong product pipeline. However, its P/E ratio of 37.1x screens as expensive against the market and industry, …